Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TransMedics (TMDX) FCF Margin (2018 - 2025)

Historic FCF Margin for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to 43.07%.

  • TransMedics' FCF Margin rose 810900.0% to 43.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 21.3%, marking a year-over-year increase of 513500.0%. This contributed to the annual value of 18.33% for FY2024, which is 499000.0% up from last year.
  • As of Q3 2025, TransMedics' FCF Margin stood at 43.07%, which was up 810900.0% from 52.45% recorded in Q2 2025.
  • TransMedics' FCF Margin's 5-year high stood at 52.45% during Q2 2025, with a 5-year trough of 174.01% in Q3 2021.
  • For the 5-year period, TransMedics' FCF Margin averaged around 52.12%, with its median value being 41.29% (2023).
  • As far as peak fluctuations go, TransMedics' FCF Margin surged by 1539300bps in 2021, and later crashed by -1054800bps in 2023.
  • Over the past 5 years, TransMedics' FCF Margin (Quarter) stood at 114.98% in 2021, then skyrocketed by 81bps to 21.67% in 2022, then tumbled by -91bps to 41.29% in 2023, then soared by 112bps to 4.98% in 2024, then soared by 765bps to 43.07% in 2025.
  • Its FCF Margin was 43.07% in Q3 2025, compared to 52.45% in Q2 2025 and 20.83% in Q1 2025.